M&A – Abliva

15 August, 2016

Regulatory

NeuroVive completes 10 percent acquisition of Isomerase Therapeutics

Lund, Sweden, August 15, 2016 - NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP, OTCQX: NEVPF), the mitochondrial medicine company, today announces that the second step in the previously announced ...

14 January, 2016

Regulatory

NeuroVive buys stake in Isomerase Therapeutics

Lund, Sweden, 14 January 2016 - NeuroVive Pharmaceutical AB (publ), the mitochondrial medicine company, announces the partial acquisition of British company Isomerase Therapeutics ("Isomerase") with t ...